Cargando…

Epidermotropic marginal zone lymphoma: An uncommon cutaneous B-cell lymphoma responsive to rituximab

Detalles Bibliográficos
Autores principales:	Magro, Cynthia M., Davis, Tracy L., Kurtzman, Drew J.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614640/ https://www.ncbi.nlm.nih.gov/pubmed/28971136 http://dx.doi.org/10.1016/j.jdcr.2017.06.024

Ejemplares similares

Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
por: Virmani, Pooja, et al.
Publicado: (2017)

Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy
por: Boudreaux, Blake W., et al.
Publicado: (2021)

Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid
por: Lee, Joon, et al.
Publicado: (2015)

Primary Cutaneous Aggressive Epidermotropic Cytotoxic T-cell Lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
por: Guitart, Joan, et al.
Publicado: (2017)

A Case of Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-Cell Lymphoma
por: Moon, Jungyoon, et al.
Publicado: (2018)

Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1
por: Merati, Miesha, et al.
Publicado: (2015)

Atypical Presentation of Primary Cutaneous CD8 Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
por: Sánchez, Aitana R., et al.
Publicado: (2019)

Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the Spleen
por: Wu, Kathie, et al.
Publicado: (2023)

Nasolabial Ulcerated Placard Revealing a Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma
por: Ntihebuwayo, J. B., et al.
Publicado: (2022)

Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
por: Alderuccio, Juan Pablo, et al.
Publicado: (2022)

Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
por: Torres, Armando N. Bastidas, et al.
Publicado: (2021)

Sequential primary cutaneous follicle center lymphoma and marginal zone B-cell lymphoma arising in the same patient
por: Alvarez, Gabriella, et al.
Publicado: (2023)

Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma
por: Kim, Kwang Min, et al.
Publicado: (2008)

A case report of primary cutaneous marginal zone B-cell lymphoma with mastocytosis
por: Lee, Hyun Yi, et al.
Publicado: (2021)

Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma
por: TRAGER, Megan H., et al.
Publicado: (2020)

Rosettes: An Additional Clue for the Identification of the Primary Cutaneous Marginal Zone Lymphoma
por: Gil, Maria Eugenia, et al.
Publicado: (2023)

Radiotherapy in marginal zone lymphoma
por: Deinbeck, Kristin, et al.
Publicado: (2013)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Chidamide combined with traditional chemotherapy for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report
por: He, Zhen-Dong, et al.
Publicado: (2022)

Probable Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma: A Case Report of a Diagnostic Challenge
por: Velarde Loya, Marcela, et al.
Publicado: (2023)

Gastric Marginal Zone B Cell Lymphoma of the Duodenum
por: Ndzengue, A., et al.
Publicado: (2011)

Extranodal pulmonary marginal zone B-cell lymphoma()
por: Yildizeli, Şehnaz Olgun, et al.
Publicado: (2016)

Marginal zone lymphomas in HIV patients
por: Genet, Philippe, et al.
Publicado: (2012)

Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
por: Maillet-Lebel, Nicole, et al.
Publicado: (2016)

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
por: Song, Ga-Young, et al.
Publicado: (2020)

Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
por: Veeraballi, Sindhusha, et al.
Publicado: (2022)

Follicular lymphoma and marginal zone lymphoma: how many diseases?
por: Laurent, Camille, et al.
Publicado: (2022)

Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases
por: Tsutsumi, Yutaka, et al.
Publicado: (2021)

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
por: Herold, Michael, et al.
Publicado: (2022)

Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly
por: Junlén, Henna‐Riikka, et al.
Publicado: (2023)

Anaplastic Lymphoma Kinase (ALK) Mutation-Targeting Treatment With Alectinib in Lung Adenocarcinoma and Primary Cutaneous Marginal Zone B-Cell Lymphoma
por: Ashish, Sethi, et al.
Publicado: (2022)

A case of primary cutaneous marginal zone lymphoma presenting with rosacea-like eruption
por: Agnihotri, Tanvir, et al.
Publicado: (2020)

Primary Cutaneous Marginal Zone Lymphoma following Repeated Inflammation Caused by Hair Dyeing
por: Lee, Jun Hyo, et al.
Publicado: (2023)

Secondary syphilis mimicking marginal zone B-cell lymphoma
por: Correia, Emily, et al.
Publicado: (2021)

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Witlox, Willem J. A., et al.
Publicado: (2020)

Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients
por: Castelli, Roberto, et al.
Publicado: (2016)

Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma
por: Li, Xiao, et al.
Publicado: (2023)

Bcl-2 expression in rituximab refractory cutaneous B-cell lymphoma
por: Wobser, M, et al.
Publicado: (2007)

Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
por: Menzer, Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tkgnoje095nd5h8k1u420fejg9